BioSpace News Archive

Study led by CHOP physicians found half of pediatric patients who were screened had no symptoms, and infection rates among children varied greatly

Growing advancements in medical and clinical field has spread awareness about requirement for better healthcare system. Governments across the globe are making amendments in research & development, and diagnostic activities, and taking initiatives for developing access to care.

Burgeoning investment in the infrastructure pertaining to healthcare is expected to bode well for the growth of the global patient positioning equipment market, states Persistence Market Research (PMR) in a research report. The report is titled, “Global Market Study on Patient Positioning Equipment: Surgical Tables Product Type Segment Expected to be the Most Attractive Segment During 2017 – 2025.”

The shoulder replacement market is expected to witness robust growth and is anticipated to grow across important regional markets in the coming years. Persistence Market Research has captured the rhythm of the global shoulder replacement market and has represented it in an insights format in a new research publication titled “Shoulder Replacement Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).”

The global rehabilitation equipment market is expected to witness sustained growth due to the rising incidences of degenerative diseases such as Parkinson’s, arthritis, etc. and a growing number of patients suffering from trauma who need rehabilitation therapy.

The University of Kentucky and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.

Aging induces various skin related problems o defects such as wrinkles, lines etc. Various medical treatments for curing these disorders are being developed. Skin rejuvenation essentially is improving the skin appearance with the help of advanced medical treatments.

Healthcare Finance Direct (HFD), a leading FinTech company, and Enova Decisions, an analytics company, today announced a strategic partnership to build the new standard of patient underwriting for elective healthcare providers.

PHILADELPHIA and OXFORDSHIRE, United Kingdom, June 04, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, today announced the closing of its previously announced underwritten public offering of its American Depositary Shares (“ADSs”). Adaptimmune sold a total of 23,575,000 ADSs at a price to the public of $11.00 per ADS, including 3,075,000 ADSs pursuant to the exercise in full by the underwriters of their option to p

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, announces that it has extended its development agreement with a leading global pharmaceutical company engaged in the research, development, manufacture and marketing of pharmaceutical products.